Related content

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

By Tsutsumi Akito   Hayashi Taichi   Chino Yusuke   Mamura Mizuko   Goto Daisuke   Matsumoto Isao   Ito Satoshi   Sumida Takayuki  

Modern Rheumatology, Vol. 16, Iss. 3, 2006-06 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite

Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?

By Sahin Mehmet   Duzgun Nursen   Tunc Sevket   Tutkak Huseyin  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 154-160

Springer Publishing Company

Access to resources Recommend Favorite

Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review

By Mattos Priscila   Santiago Mittermayer  

Clinical Rheumatology, Vol. 30, Iss. 2, 2011-02 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

The association of antibodies to cardiolipin, &bgr;2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus

By Koskenmies S   Vaarala O   Widen E   Kere J   Palosuo T   Julkunen H  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 246-252

Informa Healthcare

Access to resources Recommend Favorite

Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations

By Magalhães M. B.   da Silva L. M.   Voltarelli J. C.   Donadi E. A.   Louzada-Junior P.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 6, 2007-01 ,pp. : 442-447

Informa Healthcare

Access to resources Recommend Favorite